StonvexLoading…
StonvexStonvexStonvexCore line items from COLM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.40B | $3.37B | $3.49B | $3.46B |
Operating Income | $207.04M | $270.74M | $310.28M | $393.10M |
Net Income | $177.22M | $223.27M | $251.40M | $311.44M |
EPS (Diluted) | $3.24 | $3.82 | $4.09 | $4.95 |
Total Assets | $2.93B | $2.98B | $2.94B | $3.05B |
Total Liabilities | $1.22B | $1.20B | $1.00B | $1.12B |
Cash & Equivalents | $442.03M | $531.87M | $350.32M | $430.24M |
Free Cash Flow OCF − CapEx | $216.74M | $431.24M | $581.69M | $-83.71M |
Shares Outstanding | 54.76M | 58.50M | 61.42M | 62.97M |